University of Sydney researchers from the have secured over $22 million in funding to support medical research across 14 projects, including opioid dependence treatment programs, advancing health care for cerebral palsy patients and increasing the liver donor pool through extended organ perfusion.
This was made possible through the Australian Government’s (MRFF), which provides grant funding for clinical trials testing the effectiveness and safety of medical breakthroughs, improving health outcomes for Australians.
Deputy Vice-Chancellor (Research), Professor congratulated the recipients, noting she was particularly pleased to see that the University of Sydney was awarded the largest number of grants in Australia under the scheme.
“I’m thrilled that so many of our talented up-and-coming researchers, including from our new are being supported to uncover new discoveries and implement best practice care.”
“At Sydney, we are very focused on ensuring our research is translated to benefit society and I’m excited to see the progress these researchers will make to improve the lives of many.”
A full list of the successful MRFF grant projects awarded are below.
Clinician Researchers Applied Research in Health
Comparative trial on incubator humidity for preterm infant health
Dr and his team will expand upon their research to establish a world-first, pragmatic, randomised comparative effectiveness trial test. The testing will determine the impact of initial incubator humidity of 95% versus 80% to reduce hypernatremia, skin injury, sepsis and brain damage in extremely preterm infants.
Total funding: $1,467,697
Implementing safe, person-centred virtual care for aged care residents
Professor and team will further advance virtual care models for aged care residents through The General Practice and Residential Aged Care Study of Virtual Care Models (The Grace-VC Study).
Total funding: $1,468,436
Exploring peer-supported self-management for young psychosis patients
Dr and team will expand on their research addressing the social and mental health needs and outcomes of people with significant mental health problems. The team will conduct a hybrid-II implementation-effectiveness trial of a peer-supported self-management tools for young people in preparation for early intervention in psychosis service discharge (MY PREP- ED).
Total funding: $1,457,031
Increasing the liver donor pool through extended organ perfusion
Associate Professor and team are developing a perfusion system that can extend the survival of liver and kidney by up to 7 days. This long-term ex-vivo organ preservation is step 1 in creating the ability to evaluate, modify and optimize organs for transplantation.
Total funding: $1,188,244
Developing an integrated care model for opioid dependence treatment
Dr and team are creating and maintaining links for people in opioid dependence treatment programs with general practice care through LINK – A co-designed integrated care model.
Total funding: $1,466,168
Equitable pathways and integrated care for patients with cerebral palsy
Associate Professor and her team will further expand upon their research to evaluate a new program to reduce unmet social needs and improve health outcomes for children with cerebral palsy and their families.
Total funding: $1,464,888
Early to Mid-Career Researchers
Advancing cardiomyopathy treatment
Dr Alexander Cole and his team will further expand upon their research to enhance cardioregenerative KLF1- based therapies to treat cardiomyopathies. This research will enhance the potency of a promising therapeutic that we recently discovered can stimulate the regrowth of heart muscle.
Total funding: $994,000
Cutting-edge microtechnologies cardiovascular and cerebrovascular disease assessment
Associate Professor and his team are developing personalised and portable Point-Of-Care Testing (POCT) microtechnologies for rapid thrombotic risk and anticoagulant dosage assessment in cardiovascular and cerebrovascular diseases. The research uses ancient Chinese movable type 3D printing.
Total funding: $600,000
Multimodal hub for patients undergoing major gastrointestinal cancer surgery
Associate Professor and team will begin their PRIORITY-CONNECT 2 Pilot Trial. The clinical trial aims to determine the feasibility of incorporating a virtual multimodal program for patients undergoing gastrointestinal cancer surgery.
Total funding: $4,995,331
Using AI to improve pediatric pneumonia care
Dr and team will further expand their research in translating trustworthy causal artificial intelligence (AI) to improve decision-making and better health outcomes for children with pneumonia.
Total funding: $469,078
International Clinical Trial Collaborations
Addressing acute rejection for kidney transplant recipients
Professor and team will expand upon research to develop a multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial).
Total funding: $2,731,060
Chronic Respiratory Conditions
Technology-enhanced interventions to empower patients
Professor and her team will continue dispensing patient empowerment and self-management skills through technology enabled interventions delivered by community pharmacists.
Total funding: $1,998,235
Consumer-Led Research
Increasing treatment options and quality of life in rare disease patients
Dr Ibrahim Tohidi Esfahani and his team with further expand on Waldenström’s Macroglobulinemia patient-driven research and patient-derived data to increase knowledge of therapy options and quality of life in a rare disease.
Total funding: $324,811
Maternal Health and Healthy Lifestyles
Lifestyle programs for musculoskeletal pain in rural populations
Associate Professor team will expand upon their HeLP-R trial, which focuses on the adaptation and implementation of an effective lifestyle program for musculoskeletal pain in rural populations.
Total funding: $1,698,725
